EUVIMEDEUVIMED entdecken
Crossref

Treatment outcomes of total laryngectomy followed by localized radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma; a retrospective study

Ahmed Nabil Elsamanody, Ahmed Seleim, Mohammed Abdelfattah Eltawy, Ahmed Seddik Abdelglil Mohammed, Sherif Azzam, Eslam Mohamed M. Ibrahim, Mohamed Abdelfattah, Mohamed Abd El-Rahman Alkenawy, Ahmed Seif Elnasr Sedeek, Mahmoud Mohamed Aboumandour Fouda, Sameh Zayed, Ashraf Y. Hegab und 3 weitere

Immunopathologia Persa · 30.08.2025 · 12 (1) · e43936

DOI: 10.34172/ipp.2025.43936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunopathologia Persa, online erschienen am 30.08.2025. Verfasst von Ahmed Nabil Elsamanody und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Locally advanced laryngeal squamous cell carcinoma often requires aggressive treatment. Total laryngectomy followed by radiotherapy remains a standard approach for achieving local control and improving survival when organ preservation is not feasible.

Objectives

To evaluate the morbidity and mortality outcomes of patients with locally advanced laryngeal cancer (LC) managed with total laryngectomy followed by postoperative radiotherapy (TLPR) at a tertiary hospital in Egypt. Patients and Methods: This retrospective study included patients with a pathological diagnosis of T3 or T4 locally advanced LC treated with TLPR between 2017 and 2021, with a follow-up period of 33 months. Clinical and demographic variables, including age, gender, smoking status, tumor sub-site, TNM (tumor, node, metastasis) classification, clinical staging, pathological features, treatment modality, preoperative tracheostomy, postoperative fistula, and associated comorbidities, were collected and analyzed for their relationship to prognosis.

Results

A total of 84 patients were included in the study, with a mean age of 52.93 years (range: 26–82 years) and a male-to-female ratio of 68% to 32%. Among the patients, 45.2% achieved complete response, 28.5% had partial response, 16.8% experienced stable disease, and 9.5% showed disease progression. Frequent relapse occurred in 22 patients. The mean overall survival was 57.29 ± 62.14 weeks (range: 8–242 weeks), while the mean progression-free survival was 26.81 ± 40.92 weeks (range: 6–225 weeks).

Conclusion

Postoperative radiotherapy following total laryngectomy is an effective strategy for achieving better disease control and long-term survival in patients with locally advanced laryngeal squamous cell carcinoma.

Zitieren

APA

Elsamanody, A. N., Seleim, A., Eltawy, M. A., Mohammed, A. S. A., Azzam, S., Ibrahim, E. M. M., Abdelfattah, M., Alkenawy, M. A. E., Sedeek, A. S. E., Fouda, M. M. A., Zayed, S., Hegab, A. Y., Abood, H. B. A., Samih, T. A., & Soltan, H. A. (2025). Treatment outcomes of total laryngectomy followed by localized radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma; a retrospective study. Immunopathologia Persa, 12(1), e43936. https://doi.org/10.34172/ipp.2025.43936

Vancouver

Elsamanody AN, Seleim A, Eltawy MA, Mohammed ASA, Azzam S, Ibrahim EMM, et al. Treatment outcomes of total laryngectomy followed by localized radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma; a retrospective study. Immunopathologia Persa. 2025;12(1):e43936. doi:10.34172/ipp.2025.43936

BibTeX
@article{Elsamanody2025,
  author = {Elsamanody, Ahmed Nabil and Seleim, Ahmed and Eltawy, Mohammed Abdelfattah and Mohammed, Ahmed Seddik Abdelglil and Azzam, Sherif and Ibrahim, Eslam Mohamed M. and Abdelfattah, Mohamed and Alkenawy, Mohamed Abd El-Rahman and Sedeek, Ahmed Seif Elnasr and Fouda, Mahmoud Mohamed Aboumandour and Zayed, Sameh and Hegab, Ashraf Y. and Abood, Hashem Bark A. and Samih, Tamer A.A. and Soltan, Hasan A.},
  title = {Treatment outcomes of total laryngectomy followed by localized radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma; a retrospective study},
  journal = {Immunopathologia Persa},
  year = {2025},
  volume = {12},
  number = {1},
  pages = {e43936},
  doi = {10.34172/ipp.2025.43936}
}
Kostenlos starten →